MYnd Analytics
(NASDAQ: MYND) Webinar

Webinar Replay Registration

MYnd Analytics webinar replay now available.

Date: Thursday, April 4, 2019 at 04:00 PM EST

Duration: 20+ mins

About MYnd Analytics (NASDAQ: MYND)

MYnd Analytics, Inc. (NASDAQ: MYND), with its wholly owned subsidiary Arcadian Telepsychiatry Services LLC, is a technology-enabled telepsychiatry and teletherapy company that provides enhanced access to behavioral health services, improves patient outcomes and helps lower the costs associated with behavioral health issues. The MYnd Psychiatric EEG Evaluation Registry (PEER) is a predictive analytics decision support tool that helps physicians reduce trial and error treatment for behavioral health conditions. PEER provides the physician a personalized care plan with recommended treatment options based on a patient's unique brain markers, reducing treatment time and treatment costs. Arcadian Telepsychiatry Services LLC provides a suite of complementary telemedicine services that can be combined with PEER, including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. MYnd's customers include major health plans, health systems, and community-based organizations. To read more about the benefits of this patented technology for patients, physicians and payers, please visit:

A live Q&A session, open to current and prospective investors, will immediately follow Robin Smith – Chairman Patrick Herguth – CEO's presentation.

For more information on MYnd Analytics (NASDAQ: MYND), visit

View investor deck